100
Views
14
CrossRef citations to date
0
Altmetric
Original Article

MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers

, , , , , , & show all
Pages 665-676 | Accepted 11 Nov 1996, Published online: 04 Jan 2010

References

  • Aicher P. K., Laniado M., Kopp A. F., Grönewäller E., Duda S. H., Claussen C. D. Mn-DPDP-enhanced MR imaging of malignant liver lesions. Efficacy and safety in 20 patients. J. Magn. Reson. Imaging 1993; 3: 731
  • Asplund A., Grant D., Karlsson J. O. G. Mangafodipir (MnDPDP)- and MnCl2),-induced endothelium-dependent relaxation in bovine mesenteric arteries. J. Pharmacol. Exp. Ther. 1994; 271: 609
  • Autti T., Raininko R., Vanhanen S. L., et al. MRI of the normal brain from early childhood to middle age. Neurora-diology 1994; 36: 649
  • Bernardino M. E., Young S. W., Lee J. K. T., Weinreb J. C. Hepatic MR imaging with Mn-DPDP. Safety, image quality, and sensitivity. Radiology 1992; 183: 53
  • Brurok H., Schøjtt J., Berg K., Karlsson J. O. G., Jynge P. Effects of manganese dipyridoxal diphosphate, dipyri-doxal diphosphate, and manganese chloride on cardiac function. An experimental study in the Langendorff perfused rat heart. Invest. Radiol. 1995; 3: 159
  • Buthieau A. M., Autissier N. Effects of manganese ions on thyroid function in rat. Arch. Toxicol. 1983; 54: 243
  • Dastur D. K., Manghani D. K., Raghavendran K. V. Distribution and fate of 54Mn in the monkey. Studies of different parts of the central nervous system and other organs. J. Clin. Invest. 1971; 50: 9
  • Dastur D. K., Manghani D. K., Raghavendran K. V., Jeejeebhoy K. N. Distribution and fate of 54Mn in the rat, with special reference to the CNS. J. Exp. Physiol. 1969; 54: 322
  • DiNoto D. R., Kennedy C. D., Johnson J. A., et al. Pharma-cokinetics and biotransformation of the MRI liver contrast agent mangafodipir trisodium injection in normal male volunteers. 4th International ISSX Meeting, Seattle, Washington, 1995; 8: 323
  • Elizondo G., Fretz C. J., Stark D. D., et al. Preclinical evaluation of MnDPDP. New paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 1991; 178: 73
  • Friedheim E., Corvi C., Graziano J., Donnelli T., Breslin D. Choroid plexus as protective sink for heavy metals?. Lancet 1983; 1: 981
  • Gallez B., Bacic B., Swartz H. M. Evidence for the dissociation of the hepatobiliary MRI contrast agent MnDPDP. Magn. Reson. Med. 1996; 35: 14
  • Gehl H. B., Urhahn R., Bohndorf K., et al. Mn-DPDP in MR imaging of pancreatic adenocarcinoma. Initial clinical experience. Radiology 1993; 186: 795
  • Gehl H. B., Vorweek D., Klose K. C., Raber H., Guenther R. W. Mn-DPDP-enhanced imaging of the kidneys. First results of signal intensity changes and corticomedul-lary differentiation after low-dosage infusion. Radiology 1990; 177: 292
  • Gehl H. B., Weiss H. D., Michelsen A., Schafer R. MRI of acute pancreatitis using MnDPDP. Quantification of pancreatic injury. Eur. Radiol. 1995; 5: 282
  • Gehl H. B., Vorweek D., Klose K. C., Raber H., Guenther R. W. Mn-DPDP, the first contrast agent for the pancreas? First results of dynamic evaluation of signal intensity increases after infusion of Mn-DPDP. Radiology 1990; 177: 326
  • Gibaldi M., Perrier D. Pharmacokinetics, 2nd edn. Marcel Dekker, New York 1982
  • Grant D., Blazak W. F., Brown G. L. The reproductive toxicology of intravenously administered MnDPDP in the rat and rabbit. Acta Radiol. 1997; 38: 759
  • Grant D., Toft K. G., Martinsen I., Atzpodien E. Tissue distribution and general safety of MnDPDP in male beagle dogs, with or without total common bile duct obstruction. Acta Radiol. 1997; 38: 732
  • Grant D., Zech K., Holtz E. Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. Invest. Radiol. 1994; 29: S249
  • Hamm B., Vogl T. J., Branding G., et al. Focal liver lesions. MR imaging with Mn-DPDP — initial clinical results in 40 patients. Radiology 1992; 182: 167
  • Hustvedt S. O., Grant D., Southon T. E., Zech K. Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration. Acta Radiol. 1997; 38: 690
  • Ingersoll R. T., Aposhian H. V. Choroid plexus sequesters manganese and controls its movement from blood to CSF. Toxicologist 1992; 12: 359
  • Jynge P., Brurok H., Asplund A., . Cardiovascular safety of MnDPDP. Experience from ex vivo, in vivo animal experiments. New developments in contrast agent research, P. A. Rinck, R. N. Muller, et al. Eur. Magn. Reson. Forum, Belgium 1995; 83
  • Jynge P., Brurok H., Aspïund A., Towart R., Refsum H., Karlsson J. O. G. Cardiovascular safety of MnDPDP and MnCl2. Acta Radiol. 1997; 38: 740
  • Karlsson J. O. G., Mortensen E., Pedersen H. K., Sager G., Refsum H. Cardiovascular effecs of MnDPDP and MnCl2 in dogs with acute ischaemic heart failure. Acta Radiol. 1997; 38: 750
  • Kettritz U., Warshauser D. M., Brown E. D., Schulund J. F., Eisenberg L. B., Semelka R. C. Enhancement of the normal pancreas. Comparison of manganese-DPDP and gadolinium chelate. Eur. Radiol. 1996; 6: 14
  • Larsen L. E., Grant D. General toxicology of MnDPDP. Acta Radiol. 1997; 38: 770
  • Leander P. Liver-specific contrast media for MRI and CT. Experimental studies. Acta Radiol. Suppl. 1995; 396: 1
  • Lim O. K., Stark D. D., Leese P. T., Pfefferbaum A., Rocklage S. M., Quay S. C. Hepatobiliary MR imaging. First human experience with MnDPDP. Radiology 1991; 178: 79
  • Luoma K., Raininko R., Mummi P., Luukkonen R. Is the signal intensity of cerebrospinal fluid constant? Intensity measurements with high-and low-field magnetic resonance imagers. Magn. Reson. Imaging 1993; 11: 549
  • Mahfouz A., Coffin C., Zylbersztejn C., Rahmouni A., Mathieu D. G., Vasile N. Mn-DPDP-enhanced MR imaging of the liver. Value of fat suppression and delayed imaging. Radiology 1995; 197: 176
  • Marchal G., Zhang X., Ni Y., Vanhecke P., Yu J., Baert A. L. Comparison between Gd-DTPA, Gd-EOB-DTPA and Mn-DPDP in induced HCC in rats. Magn. Reson. Imaging 1993; 11: 665
  • Mitchell D. G., Outwater E. K., Matteucci T., Rubin D. L., Chezmar J. L., Saini S. Adrenal gland enhancement at MR imaging with MnDPDP. Radiology 1995; 194: 783
  • Muraki A. S., Carvlin M. J., Francisco J., Rocklage S. M., Quay S. MR imaging signal enhancement of normal in-tracranial and extracranial structures. Application of Mn(DPDP) as an MR contrast agent in brain. Radiology 1988; 169: 339
  • Newland M. C., Weiss B. Persistent effects of manganese on effortful responding and their relationship to manganese accumulation in the primate globus pallidus. Toxi-col. Appl. Pharmacol. 1992; 113: 87
  • Ni Y., Marchal G., Zhang X., et al. The uptake of manganese dipyridoxal-diphosphate by chemically induced heap-tocellular carcinoma in rats. Invest. Radiol. 1993; 28: 520
  • Ni Y., Marchal G., Yu J., et al. Experimental liver cancers. MnDPDP-enhanced rims in MR-microangiographic-histo-logic-correlation study. Radiology 1993; 188: 45
  • Ni Y., Petré C., Bosmans H., et al. Comparison of manganese biodistribution and MR contrast enhancement in rats after intravenous injection of MnDPDP and MnCl2. Acta Radiol. 1997; 38: 700
  • Rehnberg G. L., Hein J. F., Carter S. D., Linko R. S., Laskey J. W. Chronic ingestion of Mn3O4 by young rats. Tissue accumulation and depletion. J. Toxicol. Environ. Health 1981; 7: 263
  • Rofsky N. M., Weinreb J. C., Bernardino M. E., Young S. W., Lee J. K. T., Noz M. E. Hepatocellular tumors. Characterization with Mn-DPDP-enhanced imaging. Radiology 1993; 188: 53
  • Rofsky N. M., Weinreb J. C. Manganese (II) N,N'-dipy-ridoxylethylenediamine-N,N1-diacetate-5,51-bis(phosphate). Clinical experience with a new contrast agent. Magn. Reson. Q. 1992; 8: 156
  • Rowland M., Tucker G. Symbols in pharmacokinetics. J. Pharmacokinet. Biopharm. 1982; 14: 7
  • Rummeny E., Ehrenheim C., Gehl H. B., et al. Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Invest. Radiol. 1991; 26: S142
  • Schroeder H. A., Balassa J. J., Tipton I. H. Essential trace metals in man. Manganese, a study in homeostasis. J. Chronic Dis. 1966; 19: 545
  • Southon T. E., Grant D., Bjørnerud A., et al. NMR relaxation studies with MnDPDP. Acta Radiol. 1997; 38: 708
  • Spiller M., Brown R. D., Koenig S. H., Wolf G. L. Longitudinal proton relaxation rates in rabbit tissues after intravenous injection of free and chelated Mn2+. Magn. Reson. Med. 1988; 8: 293
  • Tirkkonen B., Aukrust A., Couture E., et al. Physico-chemical characterisation of mangafodipir trisodium. Acta Radiol. 1997; 38: 780
  • Toft K. G., Hustvedt S. O., Grant D., et al. Metabolism and pharmacokinetics of MnDPDP in man. Acta Radiol. 1997; 38: 677
  • Treinen K. A., Gray T. J. B., Blazak W. F. Developmental toxicity of mangafodipir trisodium and manganese chloride in Sprague-Dawley rats. Teratology 1995; 52: 109
  • Vogl T. J., Hamm B., Schnell B., et al. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images. J. Magn. Reson. Imaging 1993; 3: 51
  • Zheng W., Perry D. F., Nelson D., Aposhian H. V. Choroid plexus protects cerebrospinal fluid against toxic metals. FASEB, J. 1991; 5: 2188

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.